[前列腺腺癌：病理分期C. 2：治疗]
[Adenocarcinoma of the prostate: pathological stage C. 2: Treatment].
作者信息
Flam T, Zerbib M, Steg A, Debré B
机构信息
Clinique Urologique, Hôpital Cochin, Paris.
出版信息
J Urol (Paris). 1991;97(7-8):305-8.
PMID:1811022
Abstract
The discovery of a pathological stage C after radical prostatectomy with a curative aim for a clinically localized cancer of the prostate raises the question of a possible adjuvant therapy. The indications and modalities of such a therapy still remain controversial. Our review sums up our knowledge and uncertainties on this point.
摘要
对于以治愈为目的对临床局限性前列腺癌进行根治性前列腺切除术后发现病理C期，引发了关于是否可能进行辅助治疗的问题。这种治疗的适应证和方式仍然存在争议。我们的综述总结了我们在这方面的认知和不确定性。
相似文献
1
[Adenocarcinoma of the prostate: pathological stage C. 2: Treatment].[前列腺腺癌：病理分期C. 2：治疗]
J Urol (Paris). 1991;97(7-8):305-8.
2
[Total prostatectomy for stage D1 cancers].[D1期癌症的全前列腺切除术]
J Urol (Paris). 1992;98(1):14-20.
3
Radical excision of adenocarcinoma of prostate with pelvic lymph node involvement: surgical gesture or curative procedure.
Urology. 1984 Nov;24(5 Suppl):4-11.
4
Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.淋巴管浸润是前列腺腺癌的一个独立预后因素。
J Urol. 2005 Dec;174(6):2181-5. doi: 10.1097/01.ju.0000181215.41607.c3.
5
[Prostatic adenocarcinoma. III. Results of radical treatment. Review of the literature].[前列腺腺癌。III. 根治性治疗的结果。文献综述]
Actas Urol Esp. 1985 Mar-Apr;9(2):121-6.
6
Prognostic markers in clinically localized prostate cancer.临床局限性前列腺癌的预后标志物
Tech Urol. 1998 Mar;4(1):35-42.
7
8
[Adjuvant radiotherapy following radical prostatectomy--results, acute and late toxicity].前列腺癌根治术后辅助放疗——结果、急性和晚期毒性反应
Strahlenther Onkol. 1993 Mar;169(3):152-8.
9
[Radical transcoccygeal prostatectomy].[根治性经尾骨前列腺切除术]
Chir Ital. 1996;48(5):9-20.
10
[Complete radical prostatectomy and positive lymph nodes (stages pT1 to 4, N1 to 3, M0, D1)].根治性前列腺切除术与阳性淋巴结（病理分期pT1至4、N1至3、M0、D1）
Acta Urol Belg. 1998 Mar;66(1):1-6.
Zotero 插件